Published April 19, 2012 on PR Web Orlando, FL (PRWEB) April 19, 2012 As reports indicate drug maker Bayer has started settling some of the estimated 10,000 lawsuits filed over alleged side effects from its oral contraceptives Yaz and Yasmin, the FDA stepped in this month to order more protection for potential users of the Full Article…
Search LawsuitInformation.org
Judge Orders Selection of Initial Lawsuits on Avandia Heart Attacks
Published April 16, 2012 on PR Web According to court documents, on March 19th, 2012 US District Judge Cynthia Rufe ordered the beginning of the selection process of the initial Avandia lawsuits. More than 2,500 cases are consolidated before Judge Rufe in Avandia Litigation (07-01871) and plaintiffs claim to have suffered heart attacks attributed to Full Article…
FDA Demands Stronger Warning Labels for the Yaz Contraceptive
Posted April 25, 2012 on WebWire As a result of the health issues associated with the drug, the FDA has demanded that stronger warning labels be placed on Yaz packaging. WEBWIRE – Wednesday, April 25, 2012 New York, NY – Leading German pharmaceutical company, Bayer, are expected to pay out $110 million in Yaz lawsuit Full Article…
Bayer Yasmin Lawsuit Settlements Climb to $142 Million
Posted April 26, 2012 by Bloomberg Bayer AG (BAYN) said settlements of U.S. lawsuits claiming that its Yasmin line of birth-control pills caused blood clots in women have increased to $142 million. Bayer, based in Leverkusen, Germany, has resolved 651 cases alleging its Yasmin and Yaz contraceptives caused sometimes- fatal clots that can lead to Full Article…
Actos Risk How It Affects The Nations
Posted April 25, 2012 by InjuryBoard In accordance to the 2011 National Diabetes release on January 26, 2011, 25.8 million children and adults in the United States alone are diagnoses with diabetes. Type 2- diabetes is responsible for nearly 95% of diabetes cases in the United States, according to the CDC. Avandia was restricted in Full Article…
Actos Bladder Cancer Lawsuits Spike Throughout April
Posted April 26, 2012 by drugwatch A South Beach, Oregon man is among the latest of the hundreds of injured patients to seek legal justice in an Illinois court against Takeda Pharmaceuticals and the devastating diseases linked to the company’s type 2 diabetes drug Actos. The man said he started taking Actos (pioglitazone) in April Full Article…
Avandia Lawsuit Settlements
Posted April 22, 2012 Rosiglitazone, branded under Avandia and marketed as a drug to help diabetics process insulin by manufacturer GlaxoSmithKline, has been the focus of several lawsuits in the United States and Europe. Due to the reported side effects, Avandia declined in popularity and is now subject to restrictions placed by the Food and Full Article…
Transvaginal Mesh Injuries Ruin Lives FDA Slow To React
Posted April 11, 2012 on drugwatch As more women who have been victim to faulty transvaginal mesh devices across the United States come forward, medical device regulators here and in the United Kingdom continue their sluggish investigations into devices that have caused severe injuries and death. In the past months, the U.S. Food and Drug Full Article…
Bayer Begins Settling Yaz Side Effect Lawsuits
Posted April 11, 2012 on PRWeb Dallas, TX (PRWEB) April 11, 2012 With thousands of trials over alleged side effects from the birth control drugs Yaz and Yasmin set to begin, news came recently that the maker of the drugs had begun efforts to settle some of the outstanding cases. According to a federal Multi-District Full Article…
Zoloft and Propecia: New Coordinated Litigation on the Horizon? Pharma MDLs
Posted March 30, 2012 by InjuryBoard An important hearing was held on March 29, 2012, before the Judicial Panel on Multidistrict Litigation in San Diego, California. The Judicial Panel is a select group of federal judges, led by Judge John G. Heyburn II, who meet every two months at federal courthouses around the country to Full Article…
